Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Saal

Christoph Saal, Otzberg DE

Patent application numberDescriptionPublished
20090176820POLYMORPHIC FORMS AND PROCESS - The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula I07-09-2009
20110009437CARBOXAMIDE-HETEROARYL DERIVATIVES FOR THE TREATMENT OF DIABETES - Novel heterocyclic compounds of the formula I01-13-2011
201100094555-Oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-Dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of Diabetes Typ 1 and 2 - The present invention relates to novel compounds of general formula (I)01-13-2011
20110196041Novel crystal form of calcium 3-acetylaminopropane-1-sulfonate - The present invention relates to a novel crystal form of calcium 3-acetylaminopropane-1-sulfonate, to a process for the preparation thereof, and to the use thereof in medicaments.08-11-2011
20110257180Novel Polymorphic Forms of 6-(1-methyl-1H-pyrazol-4-yl)-2--2H-pyridazin-3-one Dihydrogenphosphate and Processes of Manufacturing thereof - The present invention relates to 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate, its solvates and crystalline modifications thereof. The present invention further relates to processes of manufacturing these crystalline modifications as well as their use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by the inhibition, regulation and/or modulation of signal transduction of kinases, in particular by the inhibition of tyrosine kinases, e.g. pathophysiological conditions such as cancer.10-20-2011
20110269767Novel Polymorphic Forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile Hydrochloride Salt and Processes of Manufacturing Thereof - The present invention relates to 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride solvates and crystalline modifications thereof. The present invention further relates to processes of manufacturing these crystalline modifications as well as their use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by the inhibition, regulation and/or modulation of signal transduction of kinases, in particular by the inhibition of tyrosine kinases, e.g. pathophysiological conditions such as cancer.11-03-2011

Patent applications by Christoph Saal, Otzberg DE

Klaus Saal, Munchen DE

Patent application numberDescriptionPublished
20080319888Allocation of residual value risk - Residual value risk may be allocated for a leased vehicle between a dealer organization and a manufacturer group, where the manufacturing group may include both a financing institution and a sales organization. In one embodiment, residual value risk may be allocated by first calculating a difference between a residual value for the leased vehicle and the vehicle's actual value. This difference may then be allocated between the manufacturer group and the dealer organization according to some predetermined ratio which represents a corresponding financial obligation or benefit, depending on if the difference is positive or negative.12-25-2008

Kristjan Saal, Ulenurme Parish EE

Patent application numberDescriptionPublished
20120019760METHOD OF PREPARATION OF SURFACE COATING OF VARIABLE TRANSMITTANCE AND ELECTRO-OPTICAL APPLIANCE INCLUDING THE SAME - Method of preparation of surface coating of variable transmittance and an electro-optical layered appliance including the same comprises dispersing of liquid crystal microdroplets in hydrolyzable and polymerizable precursors and applying obtained mixture on a surface by spraying. Applying the material to the surface by spraying is intrinsically related to the synthesis processes because the properties of the surrounding environment (i.e. content of water and acidity, UV radiation) and the chemical reactions that take place during spraying have considerable influence on the properties (i.e. driving voltage, thickness of obtained layer). Obtained layered appliance comprises of a matrix material with dispersed microdroplets of liquid crystal obtained by the described method, electrically conductive transparent electrodes with contacts, a dielectric material, substrate and covering layers.01-26-2012